BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7574109)

  • 1. Auxacolor, a new commercial system for yeast identification: evaluation of 182 strains comparatively with ID 32C.
    Fricker-Hidalgo H; Lebeau B; Kervroedan P; Faure O; Ambroise-Thomas P; Grillot R
    Ann Biol Clin (Paris); 1995; 53(4):221-5. PubMed ID: 7574109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the AUXACOLOR system for the identification of clinical yeast isolates.
    Milan EP; Malheiros ES; Fischman O; Colombo AL
    Mycopathologia; 1997; 137(3):153-7. PubMed ID: 9368409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of Phoenix™ Yeast ID Panel and API® ID 32C commercial systems for the identification of Candida species isolated from clinical samples].
    Gayibova Ü; Dalyan Cılo B; Ağca H; Ener B
    Mikrobiyol Bul; 2014 Jul; 48(3):438-48. PubMed ID: 25052110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of a new chromogenic medium (Candida ID) for the isolation and presumptive identification of Candida albicans and other medically important yeasts].
    Quindós G; Alonso-Vargas R; Helou S; Arechavala A; Martín-Mazuelos E; Negroni R
    Rev Iberoam Micol; 2001 Mar; 18(1):23-8. PubMed ID: 15482010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of four commercial systems for identification of medically important yeasts.
    Schuffenecker I; Freydière A; de Montclos H; Gille Y
    Eur J Clin Microbiol Infect Dis; 1993 Apr; 12(4):255-60. PubMed ID: 8513813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of yeast identification systems. An analysis of the College of American Pathologists Special Mycology Survey data.
    Fuchs PC; Dolan CT
    Am J Clin Pathol; 1982 Oct; 78(4 Suppl):664-7. PubMed ID: 7137107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the new API Candida system to the ID 32C system for identification of clinically important yeast species.
    Fricker-Hidalgo H; Vandapel O; Duchesne MA; Mazoyer MA; Monget D; Lardy B; Lebeau B; Freney J; Ambroise-Thomas P; Grillot R
    J Clin Microbiol; 1996 Jul; 34(7):1846-8. PubMed ID: 8784609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Useful phenotypic characteristics for presumptive identification of Candida guilliermondii].
    Pinoni MV; Castán V; Maegli MI; Lorenzo J; Frizzera F; Jewtuchowicz V; Mujica MT
    Rev Argent Microbiol; 2007; 39(2):81-3. PubMed ID: 17702251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the ATB 32C, automicrobic system and API 20C using clinical yeast isolates.
    Gutierrez J; Martin E; Lozano C; Coronilla J; Nogales C
    Ann Biol Clin (Paris); 1994; 52(6):443-6. PubMed ID: 7856946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of a commercial system for identification of Candida lusitaniae.
    Michel-Nguyen A; Favel A; Chastin C; Selva M; Regli P
    Eur J Clin Microbiol Infect Dis; 2000 May; 19(5):393-5. PubMed ID: 10898145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of seven commercial yeast identification systems.
    Verweij PE; Breuker IM; Rijs AJ; Meis JF
    J Clin Pathol; 1999 Apr; 52(4):271-3. PubMed ID: 10474518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a commercial multitest system for identification of yeasts.
    Qadri SM; Nichols CW
    Am J Med Technol; 1978 May; 44(5):368-72. PubMed ID: 354378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of VITEK 2 colorimetric cards versus fluorimetric cards for identification of yeasts.
    Loïez C; Wallet F; Sendid B; Courcol RJ
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):455-7. PubMed ID: 16935457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of six commercial systems for identification of medically important yeasts.
    Buchaille L; Freydière AM; Guinet R; Gille Y
    Eur J Clin Microbiol Infect Dis; 1998 Jul; 17(7):479-88. PubMed ID: 9764550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rapid identification and susceptibility to killer toxins of yeasts isolated from non-systemic mycoses].
    Sangorrín MP; Lopes CA; Rivero A; Caballero AC
    Rev Argent Microbiol; 2007; 39(4):230-6. PubMed ID: 18390160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the VITEK 2 system for rapid identification of yeasts and yeast-like organisms.
    Graf B; Adam T; Zill E; Göbel UB
    J Clin Microbiol; 2000 May; 38(5):1782-5. PubMed ID: 10790099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pasteur yeasts system, a test-kit for yeasts identification. Its evaluation in comparison with three commercial methods and conventional procedures.
    Riviera L; Bellotti MG
    Boll Ist Sieroter Milan; 1988; 67(3):245-50. PubMed ID: 3242563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of four commercialized biochemical systems for clinical yeast identification by colour-producing reactions.
    Paugam A; Benchetrit M; Fiacre A; Tourte-Schaefer C; Dupouy-Camet J
    Med Mycol; 1999 Feb; 37(1):11-7. PubMed ID: 10200929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of yeasts of the Candida genus with a growth inhibition system: Microring YT].
    Torres-Rodríguez JM; Montsant-Montané L; Madrenys-Brunet N
    Enferm Infecc Microbiol Clin; 1994 Nov; 12(9):439-42. PubMed ID: 7811770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of yeast and sensitivity in vitro against different antifungal agents].
    Muriel MA; Vizcaíno MJ; Bilbao R; Herruzo R
    Enferm Infecc Microbiol Clin; 2000 Mar; 18(3):120-4. PubMed ID: 10905013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.